Clinical trials
Phase 3 Choroidal Neovascularization trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
37 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 2 |
| 2005 | 5 |
| 2006 | 4 |
| 2007 | 2 |
| 2008 | 2 |
| 2010 | 2 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 6 |
| 2014 | 3 |
| 2015 | 1 |
| 2016 | 1 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 27 |
| Terminated | 5 |
| Unknown status | 3 |
| Active, not recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 11 |
| Novartis | 3 |
| Ophthotech Corporation | 3 |
| Alcon Research | 2 |
| Asociación para Evitar la Ceguera en México | 2 |
| Instituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBA | 2 |
| Medical University of Vienna | 2 |
| National Eye Institute (NEI) | 2 |
| AbbVie | 1 |
| Bayer | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Choroidal Neovascularization | 37 |
| Macular Degeneration | 24 |
| Vision Disorders | 5 |
| Eye Diseases | 4 |
| Geographic Atrophy | 4 |
| Wet Macular Degeneration | 4 |
| Myopia, Degenerative | 3 |
| Retinal Diseases | 3 |
| Angioid Streaks | 2 |
| Neovascularization, Pathologic | 2 |
Trials
Showing 26 to 37 of 37. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.